Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

By Hu W.   McCrea P.D.   Deavers M.   Kavanagh J.J.   Kudelka A.P.   Verschraegen C.F.  

Clinical and Experimental Metastasis, Vol. 18, Iss. 1, 2000-01 ,pp. : 83-88

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival

By Halon Agnieszka  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 511-518

Springer Publishing Company

Access to resources Recommend Favorite

CD31 Expression in Benign, Borderline, and Malignant Epithelial Ovarian Tumors: An Immunohistochemical and Serological Analysis

By Darai E.   Bringuier A.-F.   Walker-Combrouze F.   Fauconnier A.   Couvelard A.   Feldmann G.   Madelenat P.   Scoazec J.-Y.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 122-127

Elsevier

Access to resources Recommend Favorite

Treatment for Fertility and Risk of Ovarian Tumors of Borderline Malignancy

By Parazzini F.   Negri E.   La Vecchia C.   Moroni S.   Polatti A.   Chiaffarino F.   Surace M.   Ricci E.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 226-228

Elsevier

Access to resources Recommend Favorite

Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors

By Rasmussen Christina   Faber Mette   Jensen Allan   Høgdall Estrid   Høgdall Claus   Blaakær Jan   Kjaer Susanne  

Cancer Causes and Control, Vol. 24, Iss. 7, 2013-07 ,pp. : 1459-1464

Springer Publishing Company

Access to resources Recommend Favorite